4//SEC Filing
GRAHAM PETER J 4
Accession 0001016169-22-000031
CIK 0001016169other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:34 PM ET
Size
6.8 KB
Accession
0001016169-22-000031
Insider Transaction Report
Form 4
GRAHAM PETER J
SVP General Counsel, Secretary
Transactions
- Award
Common Stock
2022-03-03+26,044→ 630,244 total - Tax Payment
Common Stock
2022-03-03$3.80/sh−13,635$51,813→ 616,609 total
Footnotes (1)
- [F1]On June 13, 2019, Mr. Graham was granted a performance stock unit award that was contingent upon achieving certain performance goals over the three-year performance period ended December 31, 2021. The number of shares acquired represent the total number of shares earned upon achievement of one of the performance goals, which was certified and vested on March 3, 2022. The shares of common stock disposed represents the number of shares withheld by the company to settle tax liabilities in connection with the vesting of the performance stock unit award and were not actually sold.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001235635
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:34 PM ET
- Size
- 6.8 KB